Fludeoxyglucose Injection, Solution
Product Images NDC 24562-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose (NDC 24562-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biomedical Research Foundation Of Northwest Louisiana, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fludeoxyglucose 01)

FDA Label Image

Principal Display Panel (30 mL Vial Label)

Principal Display Panel (30 mL Vial Label)
This is a description of a fludeoxyglucose injection in a multiple-dose vial, used for diagnostic purposes through intravenous use only. It is a sterile and non-pyrogenic solution of fludeoxyglucose and sodium chloride in citrate buffer, which should not be used if cloudy or contains particulate matter. The dosage should be calculated based on the date and time of calibration, with a half-life of 109.8 minutes. It should be stored at 25°C and upright in a shielded container. This injection is manufactured for the Biomedical Research Foundation of Northwest Louisiana, located in Shreveport, LA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.